Purple Biotech Ltd. (NASDAQ: PPBT)
$0.38
+0.0038 ( +1.00% ) 109.1K
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Market Data
Open
$0.38
Previous close
$0.38
Volume
109.1K
Market cap
$12.84M
Day range
$0.37 - $0.40
52 week range
$0.30 - $1.80
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 2 | Apr 25, 2024 |
| 6-k | Quarterly Reports | 2 | Mar 28, 2024 |
| 6-k | Quarterly Reports | 2 | Mar 14, 2024 |
| 6-k | Quarterly Reports | 45 | Mar 06, 2024 |
| 6-k | Quarterly Reports | 2 | Mar 05, 2024 |
| 20-f | Annual reports | 110 | Mar 05, 2024 |
| 6-k | Quarterly Reports | 2 | Feb 27, 2024 |
| 6-k | Quarterly Reports | 2 | Feb 13, 2024 |
| 6-k | Quarterly Reports | 2 | Feb 01, 2024 |
| 6-k | Quarterly Reports | 1 | Jan 26, 2024 |